Language Selection

YOU ARE USING THE CNPHI QA SYSTEM (LIBERTY)
Français

Microimmunofluorescence (MIF)

<<Return to Search Results

Requisition Forms

Reference Details

Description:

Microimmunofluorescence (MIF) serology to test for infection by Chlamydophila psittaci.

Test Category:
Serology
Pathogen:
Chlamydophila psittaci
Illnesses and Diseases:
  • Respiratory psittacosis
Specimen:

Serum, or paired sera (preferred) – acute and convalescent. Minimum serum sample is 0.5 mL.

Collection Method:

Submit serum in a sterile 1.5 - 2 mL microcentrifuge tube.

Specimen Processing, Storage and Shipping:

Store samples in a refrigerator or frozen until shipped for testing. Ship frozen on dry ice, or on wet ice.

Transportation of Dangerous Goods:

Shipping of specimens shall be done by a TDG certified individual in accordance with TDG regulations. For additional information regarding classification of specimens for the purposes of shipping, consult either Part 2 Appendix 3 of the TDG Regulations or section 3.6.2 of the IATA Dangerous Goods Regulations as applicable.

Patient Criteria:

Patient must be symptomatic, usually immunocompromised, and has contact with an infected or exotic bird. Samples from lymphoma patients are accepted.

Accompanying Documentation:

Completed Special Bacteriology requisition form detailing all patient information and relevant clinical information. If possible, attach lab results that have already been done at local or provincial laboratories.

 

Comments:

All patient history must be included. Samples without adequate patient history to justify testing are subject to rejection.

Methods and Interpretation of Results:

Serology is performed using a commercial MIF kit (Focus Diagnostics Inc./Bio Nuclear Diagnostics Inc., Toronto ON). A four-fold or more increase of IgG titre between paired sera or IgM antibodies against C. psittaci detected by MIF to a reciprocal titre of 16 or more to satisfy the CDC confirmed case definition for psittacosis. However, the specificity of C. psittaci serology in the presence of antibodies against C. pneumoniae remains uncertain.

Turnaround Time:

15 calendar days. Please note that during times when large numbers of samples are received or if tests must be repeated, the turnaround time may be longer.

Contact:
Phone #: (204) 789-2137
Fax: (204) 784-7509
References:
  1. Beeckman, DSA and DCG Vanrompay. 2009. Zoonotic Chlamydophila psittaci infections from a clinical perspective. Clin Microbiol Infect 15: 11–17.
  2. NASPHV. Compendium of measures to control Chlamydophila psittaci infection among humans (Psittacosis) and pet birds (Avian Chlamydiosis).
  3. Reynddsburg, Ohio: National Association of State Public Health Veterinarians, 2008.
  4. Chanudet, E., et al. 2006. Chlamydia psittaci is variably associated with ocular adnexal MALT lymphoma in different geographical regions. J. Pathol. 209:344-351.
Guidelines:
Related Information: